Literature DB >> 7305608

The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms.

D S Charney, D E Sternberg, H D Kleber, G R Heninger, D E Redmond.   

Abstract

Clonidine hydrochloride was found to be effective in the treatment of methadone hydrochloride withdrawal. Under controlled inpatient conditions established to assess dosage guidelines and to examine specific signs and symptoms of withdrawal, 20 of 25 (80%) patients were able to withdraw completely from methadone by the end of a two-week period. In most patients, ten to 11 days of clonidine administration, with a peak mean dose of 16 micro g /kg/day, resulted in a perceived reduction in symptoms compared with previous attempts to become opiate free. At these doses clonidine significantly reduced standing blood pressure without producing clinical problems. The withdrawal symptoms of anxiety, restlessness, insomnia, and muscular aching were most resistant to clonidine treatment and were reported by the majority of patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7305608     DOI: 10.1001/archpsyc.1981.01780360089010

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  19 in total

Review 1.  The medical management of adolescent heroin dependence.

Authors:  A B Rowan; P J Fudala; J Mulligan
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Ambulatory opiate detoxification and primary care: a role for the primary care physician.

Authors:  P G O'Connor; M E Waugh; R S Schottenfeld; I A Diakogiannis; B J Rounsaville
Journal:  J Gen Intern Med       Date:  1992 Sep-Oct       Impact factor: 5.128

Review 3.  Neuroleptic-induced akathisia: a review.

Authors:  L A Adler; B Angrist; S Reiter; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Opiate withdrawal: inpatient versus outpatient programmes.

Authors:  C Brewer
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

Review 5.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

6.  Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys.

Authors:  J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats.

Authors:  J R Taylor; V O Lewis; J D Elsworth; P Pivirotto; R H Roth; D E Redmond
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 8.  The role of naltrexone in the management of drug abuse.

Authors:  H M Ginzburg; M G MacDonald
Journal:  Med Toxicol       Date:  1987 Mar-Apr

9.  Primary care-based ambulatory opioid detoxification: the results of a clinical trial.

Authors:  P G O'Connor; M E Waugh; K M Carroll; B J Rounsaville; I A Diagkogiannis; R S Schottenfeld
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

10.  Chronic infusion of clonidine does not alleviate spontaneous morphine withdrawal symptoms in rats.

Authors:  J W van der Laan; C Jansen van't Land
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.